Harald Gyllensvärd

Harald Gyllensvärd has extensive experience in health economics and market access strategy. Harald is currently working at Boehringer Ingelheim as a Health Economist, Market Access Strategy Manager, and Customer Team Lead. Their responsibilities include ensuring patient access to innovative medicines and leading initiatives to demonstrate their value for reimbursement. Prior to this, Harald worked at Shire as the Value Demonstration & Access Lead and Market Access Lead for the Nordic region, overseeing price reimbursement and real-world evidence projects. Harald has also held positions at the Swedish Agency for Health Technology Assessment and Assessment of Social Services, the Swedish Association of Local Authorities and Regions, The Dental and Pharmaceutical Benefits Agency, and the Swedish National Institute of Public Health, where they applied health economics in various roles.

Harald Gyllensvärd has a Licentiate degree in Medical Science from Linköping University, which was completed in 2014. Harald also has a Master's degree in Economics from Stockholm University, completed before 2005. In addition, they have completed various courses in Communication, Leadership, Health, and Coaching from different institutions including Stockholm University, Karolinska Institutet, and The Mid University, Östersund. Harald Gyllensvärd has also attended the Swedish Interdisciplinary Graduate School in Register-Based Research (SING) at Karolinska Institutet from 2011 to 2014. There is no information available about their degree or field of study from Stockholm School of Economics.